WO2014062143A3 - Combinaisons d'agent anticholinergique - Google Patents

Combinaisons d'agent anticholinergique Download PDF

Info

Publication number
WO2014062143A3
WO2014062143A3 PCT/TR2013/000313 TR2013000313W WO2014062143A3 WO 2014062143 A3 WO2014062143 A3 WO 2014062143A3 TR 2013000313 W TR2013000313 W TR 2013000313W WO 2014062143 A3 WO2014062143 A3 WO 2014062143A3
Authority
WO
WIPO (PCT)
Prior art keywords
glycopyrrolate
combinations
anticholinergic agent
anticholinergic
copd
Prior art date
Application number
PCT/TR2013/000313
Other languages
English (en)
Other versions
WO2014062143A2 (fr
Inventor
Mahmut Bilgic
Original Assignee
Mahmut Bilgic
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mahmut Bilgic filed Critical Mahmut Bilgic
Publication of WO2014062143A2 publication Critical patent/WO2014062143A2/fr
Publication of WO2014062143A3 publication Critical patent/WO2014062143A3/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La présente invention concerne des compositions pharmaceutiques comprenant glycopyrrolate et un agent anticholinergique destinées à être utilisées dans le traitement de l'asthme et de la maladie pulmonaire obstructive chronique (COPD).
PCT/TR2013/000313 2012-10-19 2013-10-11 Combinaisons d'agent anticholinergique WO2014062143A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
TR201212053 2012-10-19
TR2012/12053 2012-10-19

Publications (2)

Publication Number Publication Date
WO2014062143A2 WO2014062143A2 (fr) 2014-04-24
WO2014062143A3 true WO2014062143A3 (fr) 2014-07-17

Family

ID=50000067

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/TR2013/000313 WO2014062143A2 (fr) 2012-10-19 2013-10-11 Combinaisons d'agent anticholinergique

Country Status (1)

Country Link
WO (1) WO2014062143A2 (fr)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005107872A2 (fr) * 2004-05-10 2005-11-17 Sosei R&D Ltd. Traitement d'une maladie respiratoire
WO2005107873A2 (fr) * 2004-05-10 2005-11-17 Sosei R&D Ltd. Traitement de l'asthme infantile
US20070287727A1 (en) * 2006-06-08 2007-12-13 Jacob Hiller Anti-Nicotine Treatment
WO2012028745A1 (fr) * 2010-09-03 2012-03-08 Pharmaterials Limited Composition pharmaceutique adaptée pour une utilisation dans un inhalateur de poudre sèche

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2956062A (en) 1959-02-26 1960-10-11 Robins Co Inc A H Esters of amino alcohols

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005107872A2 (fr) * 2004-05-10 2005-11-17 Sosei R&D Ltd. Traitement d'une maladie respiratoire
WO2005107873A2 (fr) * 2004-05-10 2005-11-17 Sosei R&D Ltd. Traitement de l'asthme infantile
US20070287727A1 (en) * 2006-06-08 2007-12-13 Jacob Hiller Anti-Nicotine Treatment
WO2012028745A1 (fr) * 2010-09-03 2012-03-08 Pharmaterials Limited Composition pharmaceutique adaptée pour une utilisation dans un inhalateur de poudre sèche

Also Published As

Publication number Publication date
WO2014062143A2 (fr) 2014-04-24

Similar Documents

Publication Publication Date Title
IL257581A (en) New dihydropyrimidineisoquinolinones and their pharmaceutical preparations for the treatment of inflammatory disorders
HK1209788A1 (en) Methods and compositions for the treatment of lysosomal storage diseases
WO2014031610A8 (fr) Procédés permettant de traiter ou d'empêcher l'asthme par administration d'un antagoniste du récepteur à l'interleukine 4 (il-4r)
WO2012174487A3 (fr) Inhibiteurs à bromodomaine et leurs utilisations
EP2847152A4 (fr) Compositions et méthodes de traitement du syndrome métabolique
HK1180320A1 (en) Pyrimidine derivatives and their use in the treatment of respiratory diseases such as copd copd
EP2585084A4 (fr) Compositions micronisées de tissu placentaire, et méthodes de fabrication et d'utilisation de celles-ci
WO2012110770A3 (fr) Composition pharmaceutique
HK1180322A1 (en) Pyrimidine derivatives and their use in the treatment of respiratory diseases such as copd copd
WO2012075383A3 (fr) Inhibiteurs de bromodomaines et leurs utilisations
PL2627334T3 (pl) Kompozycje do stosowania w leczeniu zakażeń wirusowych
EP2721151A4 (fr) Thérapie anti-tnf contre les mucopolysaccharidoses et d'autres maladies lysosomiales
EP2411003A4 (fr) Utilisation de dérivés de l'artémisinine dans le traitement de l'asthme et de la broncho-pneumopathie obstructive chronique (bpco)
PT2900247T (pt) Composições contendo plasma tratado com dissolventes/detergentes e ácido hialurónico para serem utilizadas no tratamento de distúrbios músculo-esqueléticos
WO2013016205A3 (fr) Compositions et méthodes pour réduire l'incidence de troubles digestifs chez des équidés
PL2903608T3 (pl) Kompozycja farmaceutyczna obejmująca kwas propionowy do stosowania w leczeniu infekcji wirusowych
WO2014182928A3 (fr) Inhibiteurs de stat6
MX2016001539A (es) Particulas inhalables que comprenden tiotropio e indacaterol.
HK1212902A1 (zh) 諸如 的鈣/陽離子感應受體 拮抗劑在治療炎性肺病 哮喘或 中的應用
WO2012030308A3 (fr) Formulation comprenant la cellobiose
WO2012158493A3 (fr) Composés qui se lient au récepteur d'érythropoïétine
WO2014062143A3 (fr) Combinaisons d'agent anticholinergique
IL234009B (en) Compositions containing s-modafinil for substitution therapy in cocaine addicts
EP2823818A4 (fr) Utilisation de la rupatadine dans la fabrication d'une composition pharmaceutique pour le traitement de la bronchopneumopathie chronique obstructive
EP2677868A4 (fr) Compositions pharmaceutiques de maraviroc et leur procédé de préparation

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 13824041

Country of ref document: EP

Kind code of ref document: A2

122 Ep: pct application non-entry in european phase

Ref document number: 13824041

Country of ref document: EP

Kind code of ref document: A2